Literature DB >> 18040253

Autofluorescence of basal laminar drusen.

Catherine B Meyerle1, R Theodore Smith, Irene A Barbazetto, Lawrence A Yannuzzi.   

Abstract

PURPOSE: To compare noninvasive autofluorescence (AF) photography with conventional fundus photography and fluorescein angiography (FA) in the detection of basal laminar drusen (BLD).
METHODS: A retrospective case review of 20 patients with BLD studied with AF and conventional imaging was performed. Three selected patients with different degrees of BLD are presented. AF imaging employed an excitation filter at 580 nm and a barrier filter at 695 nm with acquisition by a Topcon 50X fundus camera. Corresponding detail regions in each image were enlarged for comparison. The AF detail image was registered by a projective transformation in Matlab (Mathworks 7.0, Natick, MA) with the color photograph/red free photograph (RF) and/or FA image detail for exact superimposition in Photoshop and lesion comparison.
RESULTS: Each visible drusen in the color or RF photograph corresponded when superimposed to a focal hypoautofluorescent lesion in the AF image. However, similar to the starry sky pattern in FA, the AF lesions significantly outnumbered the clinically evident drusen. When BLD lesions were not advanced enough to show the classic starry sky fluorescein hyperfluorescence, the BLD were detectable with AF.
CONCLUSIONS: In our case series, AF imaging demonstrated a higher level of sensitivity when compared with conventional fundus photography and is less invasive than FA for the detection of BLD. Fundus AF, therefore, is valuable for diagnosing and following BLD, particularly since these patients are at risk for development of pseudovitelliform detachment which may simulate CNV.

Entities:  

Mesh:

Year:  2007        PMID: 18040253      PMCID: PMC2771561          DOI: 10.1097/IAE.0b013e3181451617

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration.

Authors:  S R Russell; R F Mullins; B L Schneider; G S Hageman
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

2.  Diffuse drusen and associated complications.

Authors:  K R Kenyon; A E Maumenee; S J Ryan; P V Whitmore; W R Green
Journal:  Am J Ophthalmol       Date:  1985-07-15       Impact factor: 5.258

3.  Automated detection of macular drusen using geometric background leveling and threshold selection.

Authors:  R Theodore Smith; Jackie K Chan; Takayuki Nagasaki; Umer F Ahmad; Irene Barbazetto; Janet Sparrow; Marta Figueroa; Joanna Merriam
Journal:  Arch Ophthalmol       Date:  2005-02

4.  Adult vitelliform macular detachment occurring in patients with basal laminar drusen.

Authors:  J D Gass; S Jallow; B Davis
Journal:  Am J Ophthalmol       Date:  1985-04-15       Impact factor: 5.258

  4 in total
  5 in total

1.  Complement factor H 402H variant and reticular macular disease.

Authors:  R Theodore Smith; Joanna E Merriam; Mahsa A Sohrab; Nicole M Pumariega; Gaetano Barile; Anna M Blonska; Raymond Haans; David Madigan; Rando Allikmets
Journal:  Arch Ophthalmol       Date:  2011-08

2.  Quantification of fluorescein-stained drusen associated with age-related macular degeneration.

Authors:  Duncan Friedman; John S Parker; James A Kimble; François C Delori; Gerald McGwin; Christine A Curcio
Journal:  Retina       Date:  2012-01       Impact factor: 4.256

3.  Reticular macular disease.

Authors:  R Theodore Smith; Mahsa A Sohrab; Mihai Busuioc; Gaetano Barile
Journal:  Am J Ophthalmol       Date:  2009-11       Impact factor: 5.258

Review 4.  Clinical application of ultra-widefield fundus autofluorescence.

Authors:  Amin Xu; Changzheng Chen
Journal:  Int Ophthalmol       Date:  2020-10-11       Impact factor: 2.031

5.  Clinical manifestations of cuticular drusen in Korean patients.

Authors:  Dong Hoon Shin; Mingui Kong; Gyule Han; Jong Chul Han; Don-Il Ham
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.